Loading...
XNYS
HIMS
Market cap7.91bUSD
Jul 09, Last price  
35.45USD
1D
-1.72%
1Q
82.45%
IPO
256.28%
Name

Hims & Hers Health Inc

Chart & Performance

D1W1MN
XNYS:HIMS chart
P/E
61.61
P/S
3.37
EPS
0.58
Div Yield, %
Shrs. gr., 5y
48.84%
Rev. gr., 5y
73.63%
Revenues
2.35b
+59.00%
26,679,00082,558,000148,757,000271,878,000526,916,000872,000,0001,476,514,0002,347,637,000
Net income
128m
+1.85%
-75,243,000-72,064,000-18,114,000-107,659,000-65,678,000-23,546,000126,038,000128,365,000
CFO
300m
+19.48%
-57,322,000-74,867,000-2,479,000-34,412,000-26,531,00073,483,000251,084,000300,006,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
IPO date
Sep 09, 2019
Employees
651
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT